NDUFA4L2 reduces mitochondrial respiration resulting in defective lysosomal trafficking in clear cell renal cell carcinoma

ABSTRACT In clear cell renal cell carcinoma (ccRCC), activation of hypoxic signaling induces NADH dehydrogenase (ubiquinone) 1 alpha subcomplex, 4-like 2 (NDUFA4L2) expression. Over 90% of ccRCCs exhibit overexpression of NDUFA4L2, which we previously showed contributes to ccRCC proliferation and survival. The function of NDUFA4L2 in ccRCC has not been fully elucidated. NDUFA4L2 was reported to reduce mitochondrial respiration via mitochondrial complex I inhibition. We found that NDUFA4L2 expression in human ccRCC cells increases the extracellular acidification rate, indicative of elevated glycolysis. Conversely, NDUFA4L2 expression in non-cancerous kidney epithelial cells decreases oxygen consumption rate while increasing extracellular acidification rate, suggesting that a Warburg-like effect is induced by NDUFA4L2 alone. We performed mass-spectrometry (MS)-based proteomics of NDUFA4L2 associated complexes. Comparing RCC4-P (parental) ccRCC cells with RCC4 in which NDUFA4L2 is knocked out by CRISPR-Cas9 (RCC4-KO-643), we identified 3,215 proteins enriched in the NDUFA4L2 immunoprecipitates. Among the top-ranking pathways were “Metabolic Reprogramming in Cancer” and “Glycolysis Activation in Cancer (Warburg Effect).” We also show that NDUFA4L2 enhances mitochondrial fragmentation, interacts with lysosomes, and increases mitochondrial-lysosomal associations, as assessed by high-resolution fluorescence microscopy and live cell imaging. We identified 161 lysosomal proteins, including Niemann-Pick Disease Type C Intracellular Cholesterol Transporters 1 and 2 (NPC1, NPC2), that are associated with NDUFA4L2 in RCC4-P cells. RCC4-P cells have larger and decreased numbers of lysosomes relative to RCC4 NDUFA4L2 knockout cells. These findings suggest that NDUFA4L2 regulates mitochondrial-lysosomal associations and potentially lysosomal size and abundance. Consequently, NDUFA4L2 may regulate not only mitochondrial, but also lysosomal functions in ccRCC.

[1]  F. Khani,et al.  Mitochondrial Ndufa4l2 Enhances Deposition of Lipids and Expression of Ca9 in the TRACK Model of Early Clear Cell Renal Cell Carcinoma , 2021, Frontiers in Oncology.

[2]  R. Gillies,et al.  Extracellular Acidification Induces Lysosomal Dysregulation , 2021, Cells.

[3]  Shi-ting Li,et al.  NDUFA4L2 promotes glioblastoma progression, is associated with poor survival, and can be effectively targeted by apatinib , 2021, Cell Death & Disease.

[4]  Kathleen M. Jagodnik,et al.  Gene Set Knowledge Discovery with Enrichr , 2021, Current protocols.

[5]  G. Grosveld,et al.  Lysosomes and Cancer Progression: A Malignant Liaison , 2021, Frontiers in Cell and Developmental Biology.

[6]  C. Porta,et al.  Lenvatinib plus Pembrolizumab or Everolimus for Advanced Renal Cell Carcinoma. , 2021, The New England journal of medicine.

[7]  R. Wolthuis,et al.  Loss of FLCN-FNIP1/2 induces a non-canonical interferon response in human renal tubular epithelial cells , 2021, eLife.

[8]  A. Jemal,et al.  Cancer Statistics, 2021 , 2021, CA: a cancer journal for clinicians.

[9]  Emma Y. Wu,et al.  NPC1-mTORC1 signaling Couples Cholesterol Sensing to Organelle Homeostasis and is a Targetable Pathway in Niemann-Pick type C , 2020, bioRxiv.

[10]  P. D. Dal Cin,et al.  Carbonic anhydrase IX (CA9) expression in multiple renal epithelial tumour subtypes , 2020, Histopathology.

[11]  Michael G. Kharas,et al.  Convergent organization of aberrant MYB complex controls oncogenic gene expression in acute myeloid leukemia , 2020, bioRxiv.

[12]  Sang Gyun Kim,et al.  Rap1-GTPases control mTORC1 activity by coordinating lysosome organization with amino acid availability , 2020, Nature Communications.

[13]  A. Ballabio,et al.  Lysosomes as dynamic regulators of cell and organismal homeostasis , 2019, Nature Reviews Molecular Cell Biology.

[14]  L. Huber,et al.  Lysosomal size matters , 2019, Traffic.

[15]  Bonnie F. Sloane,et al.  Acidosis and proteolysis in the tumor microenvironment , 2019, Cancer and Metastasis Reviews.

[16]  Jürgen Cox,et al.  MaxQuant.Live Enables Global Targeting of More Than 25,000 Peptides , 2018, Molecular & Cellular Proteomics.

[17]  R. Zoncu,et al.  The lysosome as a cellular centre for signalling, metabolism and quality control , 2019, Nature Cell Biology.

[18]  E. Boyden,et al.  Expansion microscopy: principles and uses in biological research , 2018, Nature Methods.

[19]  L. Szente,et al.  Hydroxypropyl-beta and -gamma cyclodextrins rescue cholesterol accumulation in Niemann–Pick C1 mutant cell via lysosome-associated membrane protein 1 , 2018, Cell Death & Disease.

[20]  P. De Camilli,et al.  VPS13A and VPS13C are lipid transport proteins differentially localized at ER contact sites , 2018, The Journal of cell biology.

[21]  B. Warscheid,et al.  Vps39 Interacts with Tom40 to Establish One of Two Functionally Distinct Vacuole-Mitochondria Contact Sites. , 2018, Developmental cell.

[22]  Y. Ciribilli,et al.  LAMPs: Shedding light on cancer biology. , 2017, Seminars in oncology.

[23]  Charles Swanton,et al.  Renal cell carcinoma , 2017, Nature Reviews Disease Primers.

[24]  Roberto Zoncu,et al.  The Lysosome as a Regulatory Hub. , 2016, Annual review of cell and developmental biology.

[25]  Q. Tang,et al.  Niemann-Pick type C2 deficiency impairs autophagy-lysosomal activity, mitochondrial function, and TLR signaling in adipocytes , 2016, Journal of Lipid Research.

[26]  G. Blobel,et al.  Clues to the mechanism of cholesterol transfer from the structure of NPC1 middle lumenal domain bound to NPC2 , 2016, Proceedings of the National Academy of Sciences.

[27]  Andrew D. Rouillard,et al.  Enrichr: a comprehensive gene set enrichment analysis web server 2016 update , 2016, Nucleic Acids Res..

[28]  R. Amaravadi,et al.  Targeting the lysosome in cancer , 2016, Annals of the New York Academy of Sciences.

[29]  I. Ng,et al.  NDUFA4L2 Fine-tunes Oxidative Stress in Hepatocellular Carcinoma , 2016, Clinical Cancer Research.

[30]  N. Mongan,et al.  Role of NADH Dehydrogenase (Ubiquinone) 1 Alpha Subcomplex 4-Like 2 in Clear Cell Renal Cell Carcinoma , 2016, Clinical Cancer Research.

[31]  J. Redondo,et al.  Mitochondrial Respiration Controls Lysosomal Function during Inflammatory T Cell Responses. , 2015, Cell metabolism.

[32]  B. Robinson,et al.  Analyses of the Transcriptome and Metabolome Demonstrate That HIF1α Mediates Altered Tumor Metabolism in Clear Cell Renal Cell Carcinoma , 2015, PloS one.

[33]  D. Nanus,et al.  Genome-Wide Profiling of TRACK Kidneys Shows Similarity to the Human ccRCC Transcriptome , 2015, Molecular Cancer Research.

[34]  P. Agostinis,et al.  Autophagy and mitophagy interplay in melanoma progression. , 2014, Mitochondrion.

[35]  B. van Steensel,et al.  Easy quantitative assessment of genome editing by sequence trace decomposition , 2014, Nucleic acids research.

[36]  M. van der Laan,et al.  Cellular metabolism regulates contact sites between vacuoles and mitochondria. , 2014, Developmental cell.

[37]  M. Schuldiner,et al.  A dynamic interface between vacuoles and mitochondria in yeast. , 2014, Developmental cell.

[38]  W Marston Linehan,et al.  Intratumoral heterogeneity in kidney cancer , 2014, Nature Genetics.

[39]  Edward Y. Chen,et al.  Enrichr: interactive and collaborative HTML5 gene list enrichment analysis tool , 2013, BMC Bioinformatics.

[40]  S. Batra,et al.  Incidence and Prognostic Significance of Second Primary Cancers in Renal Cell Carcinoma , 2013, American journal of clinical oncology.

[41]  B. Westermann Bioenergetic role of mitochondrial fusion and fission. , 2012, Biochimica et biophysica acta.

[42]  J. Enríquez,et al.  Induction of the mitochondrial NDUFA4L2 protein by HIF-1α decreases oxygen consumption by inhibiting Complex I activity. , 2011, Cell metabolism.

[43]  M. Ashcroft,et al.  Inactivation of the von Hippel-Lindau tumour suppressor gene induces Neuromedin U expression in renal cancer cells , 2011, Molecular Cancer.

[44]  I. Weissman,et al.  VHL loss in renal cell carcinoma leads to up-regulation of CUB domain-containing protein 1 to stimulate PKCδ-driven migration , 2011, Proceedings of the National Academy of Sciences.

[45]  G. Semenza,et al.  HIF-1 mediates the Warburg effect in clear cell renal carcinoma , 2007, Journal of bioenergetics and biomembranes.

[46]  G. Millat,et al.  Niemann‐Pick type C disease: Subcellular location and functional characterization of NPC2 proteins with naturally occurring missense mutations , 2005, Human mutation.

[47]  M. Solaiyappan,et al.  Extracellular acidification alters lysosomal trafficking in human breast cancer cells. , 2003, Neoplasia.

[48]  H. Gröne,et al.  Constitutive activation of hypoxia-inducible genes related to overexpression of hypoxia-inducible factor-1alpha in clear cell renal carcinomas. , 2001, Cancer research.

[49]  C. Wykoff,et al.  The tumour suppressor protein VHL targets hypoxia-inducible factors for oxygen-dependent proteolysis , 1999, Nature.

[50]  J. Haines,et al.  Von Hippel–Lindau disease maps to the region of chromosome 3 associated with renal cell carcinoma , 1988, Nature.

[51]  O. Warburg [Origin of cancer cells]. , 1956, Oncologia.